Top Buy
| Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc. | 14 | 5 | 3 | 0 | €31.00 | €41.51 | 33.911% |
| Rhythm Pharmaceuticals | 14 | 0 | 2 | 0 | €40.60 | €46.19 | 13.756% |
| EyePoint Pharmaceuticals Inc. | 14 | 1 | 0 | 1 | €18.33 | €28.17 | 53.670% |
| Bayer AG | 15 | 1 | 0 | 0 | €28.15 | €50.00 | 77.620% |
| G1 Therapeutics | 15 | 1 | 3 | 0 | €4.14 | €10.05 | 143.085% |
| Krystal Biotech | 16 | 0 | 3 | 0 | €149.55 | €173.22 | 15.826% |
| Abbott Laboratories | 16 | 0 | 2 | 0 | €98.38 | €116.81 | 18.731% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 4 | 0 | €39.80 | €84.74 | 112.925% |
| Novo Nordisk A/S ADR | 17 | 1 | 1 | 0 | €114.50 | €130.00 | 13.537% |
| Natural Alternat. | 17 | 1 | 0 | 0 | €5.75 | - | - |
| United Therapeutics | 18 | 0 | 3 | 0 | €243.70 | €288.66 | 18.449% |
| Icon plc | 18 | 0 | 4 | 0 | €280.90 | €319.67 | 13.802% |
| Sutro Biopharma Inc | 18 | 0 | 0 | 0 | €3.42 | €11.05 | 223.053% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €20.62 | €26.01 | 26.122% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €12.68 | €25.20 | 98.839% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | €76.62 | €102.62 | 33.932% |
| AbbVie Inc. | 21 | 0 | 4 | 0 | €152.18 | €174.43 | 14.623% |
| Zoetis Inc. A | 21 | 1 | 3 | 1 | €155.28 | €200.06 | 28.837% |
| TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €15.05 | €28.06 | 86.426% |
| Trinity Biotech ADR | 22 | 0 | 1 | 0 | €0.41 | - | - |
| Intra-Cellular Therapies Inc. | 23 | 0 | 7 | 0 | €64.00 | €79.43 | 24.109% |
| Jazz Pharmaceuticals plc | 23 | 0 | 4 | 0 | €102.25 | €184.92 | 80.851% |
| Amgen Inc. | 23 | 0 | 4 | 0 | €289.20 | €298.90 | 3.353% |
| Cytokinetics Inc. | 24 | 1 | 3 | 0 | €61.00 | €83.81 | 37.401% |
| Neurocrine Bioscience | 27 | 0 | 7 | 0 | €130.70 | €140.34 | 7.376% |